Drug Profile
Research programme: Alzheimer's disease DNA vaccine - VITRUVIAN BioMedical/Nuron Biotech
Alternative Names: Amyloid beta 42 DNA vaccine for Alzheimer's disease - Nuron BiotechLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator University of Texas Southwestern Medical Center
- Developer VITRUVIAN BioMedical
- Class Alzheimer vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease